மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மருத்துவ மையம் ஆராய்ச்சி நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் Today - Breaking & Trending Today

$940K federal grant will fund MaineHealth research into COVID testing

$940K federal grant will fund MaineHealth research into COVID testing
mainebiz.biz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mainebiz.biz Daily Mail and Mail on Sunday newspapers.

United States , Maine Medical Center , Elizabeth Jacobs , Angus King , Mark Swann , Kathleen Fairfield , Maine Medical Center Research Institute , National Institutes Of Health , Greater Portland Health , Portland Public Health Division , National Institutes , American Rescue Plan , Medical Center Research Institute , Preble Street , Street Executive Director Mark Swann , Public Health Division , ஒன்றுபட்டது மாநிலங்களில் , மைனே மருத்துவ மையம் , எலிசபெத் ஜாகோப்ஸ் , அங்குஸ் கிங் , குறி ஸ்வான் , க்யாத்லீந் ஃபேர்ஃபீல்ட் , மைனே மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் , தேசிய நிறுவனங்கள் ஆஃப் ஆரோக்கியம் , அதிகமானது போர்டிலந்ட் ஆரோக்கியம் , போர்டிலந்ட் பொது ஆரோக்கியம் பிரிவு ,

SynDevRx Announces Research Collaboration with Maine Medical Center Research Institute to Study the Effects of SDX-7320 In Obesity-Accelerated Multiple Myeloma Models

SynDevRx Announces Research Collaboration with Maine Medical Center Research Institute to Study the Effects of SDX-7320 In Obesity-Accelerated Multiple Myeloma Models
prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , United States , Peter Cornelius , Michaela Reagan , James Shanahan , Maine Medical Center Research Institute Michaela Reagan , Maine Medical Center Research Institute , Syndevrx Inc , Maine Medical Center , Translational Research , Medical Center , Chief Business Officer James , Medical Center Research Institute , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , பீட்டர் கார்னெலியஸ் , மைக்கேலா ரீகந் , ஜேம்ஸ் ஶ்யாநஹ்யாந் , மைனே மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் , மைனே மருத்துவ மையம் , மொழிபெயர்ப்பு ஆராய்ச்சி , மருத்துவ மையம் , மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் ,

Kojin Therapeutics Debuts to Solve Difficult Diseases Through Cell Behavior

Published: Jun 09, 2021
By Mark Terry
Kojin Therapeutics
launched with a $60 million Series A to initially focus on oncology and cell state biology. The round was led by Polaris Partners, Newpath Partners, and Cathay Health, affiliated to Cathay Capital. Participants included Leaps by Bayer, AbbVie, Eventide Asset Management, Alexandria, the Dana-Farber Cancer Institute’s Binney Street Capital, and several family offices.
The approach came out of the
laboratoryof Stuart Schreiber, Harvard University professor and co-founder of the Broad Institute. Co-founders of Kojin include Benjamin Cravatt, Stephanie Dougan and Vasanthi Viswanathan. The company’s technology is ferroptosis-based drug discovery, which is to say, iron-dependent cell death. Kojin says that difficult-to-treat diseases, which includes drug-resistant cancers, involve diseased cells that are sensitive to ferroptosis. ....

United States , Al Iskandariyah , Harvard University , Dana Farber Cancer Institute , Jurgen Eckhardt , Amir Nashat , Benjamin Cravatt , Stephanie Dougan , Joel Barrish , Steve Davidsen , Nagesh Mahanthappa , Susan Langer , Vasanthi Viswanathan , Nortonb Gilula , Stuart Schreiber , Kay Ahn , Sean Morrison , Scripps Research Institute , Broad Institute , Sarcoma Center At Dana Farber , Harvard Medical School , Ludwig Center At Dana Farber Harvard Cancer , Cathay Health , Children Medical Center Research Institute , Department Of Chemistry , Schreiber Lab ,

Communicating Scientific Uncertainty About the COVID-19 Pandemic: Online Experimental Study of an Uncertainty-Normalizing Strategy

Han, Scharnetzki, Lary, Waterston); University of Iowa Carver College of Medicine (
Scherer); University of Utah (
Fagerlin); Oregon Health and Science University (
Dieckmann)
.a strategy aimed at normalizing uncertainty as an expected state of affairs was effective in reducing at least some aversive psychological responses to the communication of uncertainty, whereas widely used alternative strategies aimed at promoting hope and prosocial values had no such effect.
Expert guidelines on crisis communication stress the importance of acknowledging uncertainty - a defining feature of public health crises such as COVID-19 - in order to foster public accountability and trust. However, the communication of scientific uncertainty has the potential to promote negative cognitive, emotional, and behavioural responses, such as heightened risk perceptions, emotional distress, and decision avoidance. This study evaluates whether a communication strategy emphasising that ....

United States , Salt Lake City , Paul Kj Han , Alistair Thorpe , Leob Waterston , Christine Lary , Elizabeth Scharnetzki , Aaronm Scherer , Angela Fagerlin , Nathanf Dieckmann , Maine Medical Center Research Institute Han , Salt Lake City Va Center , University Of Utah Thorpe , Science University Dieckmann , Oregon Health , Medical Center Research Institute , Iowa Carver College , Informatics Decision Enhancement , Science University , Hiv Aids , United Nations , ஒன்றுபட்டது மாநிலங்களில் , உப்பு ஏரி நகரம் , பால் க்ஜ் ஹான் , அலிஸ்டர் தோர்ப் , ஓரிகந் ஆரோக்கியம் ,

'Jumping' genes can prevent blood cancers: Study

Jumping genes can prevent blood cancers: Study
By
IANS
|
4 Views
Gallbladder, biliary tract cancer cases up 76% in 3 decades. Image Source: IANS News
New York, April 9 : US scientists have found that transposons, also known as jumping genes, can protect against certain blood cancers and help develop new therapeutic targets.
Transposons are DNA sequences that can move, or jump, from one location in the genome to another when activated. These jumping genes are a source of genetic mutations responsible for a number of human diseases.
The findings, published in the journal Nature Genetics, can help predict how patients will respond to cancer therapies and find new therapeutic targets for acute myeloid leukemia (AML) the deadliest type of blood cancer in adults and children. ....

New York , United States , Jian Xu , Children Medical Center Research Institute , University Of Texas Southwestern , Nature Genetics , Medical Center Research Institute , Texas Southwestern , Associate Professor , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , ஜியான் ஐயூ , குழந்தைகள் மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் தென்மேற்கு , இயற்கை ஜெநெடிக்ஸ் , மருத்துவ மையம் ஆராய்ச்சி நிறுவனம் , டெக்சாஸ் தென்மேற்கு , இணை ப்ரொஃபெஸர் ,